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INTRODUCTION
Glomerulonephritis (GN) is a major cause of human kidney failure,
with the formation of glomerular epithelial crescents being a
common feature in its most severe forms. Crescentic
glomerulonephritis (CRGN) is characterised by the appearance of
glomerular crescents formed by the accumulation of inflammatory
cells and proliferating epithelial cells in Bowman’s space. Untreated
CRGN most often leads to rapidly progressive glomerulonephritis
followed by end-stage renal disease (Feehally et al., 2005).
The Wistar Kyoto (WKY) rat strain is highly susceptible to
experimental models of CRGN, including nephrotoxic nephritis
(NTN) and experimental autoimmune glomerulonephritis (EAG)
(Reynolds et al., 2003; Tam et al., 1999). The WKY models of NTN
and EAG closely resemble human CRGN histologically (Reynolds
et al., 2003; Tam et al., 1999; Tarzi et al., 2011). NTN has been used
widely as a model for studying mechanisms of crescent formation
and factors leading to glomerulosclerosis and renal failure in
CRGN (Aitman et al., 2006; Behmoaras et al., 2008; Behmoaras et
al., 2010; Cook et al., 1999; Smith et al., 2007; Tam et al., 1999),
whereas EAG has been used as a model of autoantibody production
and autoimmune glomerular injury (Reynolds et al., 2012; Reynolds
et al., 2002; Reynolds et al., 2003; Ryan et al., 2001). In the WKY
rat, a single injection of nephrotoxic serum (NTS) leads to
proteinuria, glomerular macrophage infiltration and glomerular
crescent formation in 90% of glomeruli with progression to severe
scarring with renal failure by week 6 (Behmoaras et al., 2008; Cook
et al., 1999; Tam et al., 1999), whereas rat strains such as Lewis
(LEW) and Brown Norway are resistant. The LEW strain shares
the same MHC haplotype (RT1l) but shows resistance to CRGN
following NTS and has therefore been used as a negative control
in CRGN (Aitman et al., 2006; Behmoaras et al., 2008; Behmoaras
et al., 2010; Maratou et al., 2011; Page et al., 2012; Smith et al.,
2007).
Previously, we studied the genetic susceptibility to NTN in the
WKY rat by using segregating populations derived from WKY and
LEW rats. Genome-wide linkage analysis carried out on (WKY ×
LEW) F2 offspring detected seven significant quantitative trait loci
(QTLs) for CRGN susceptibility (Aitman et al., 2006). Of these,
two major QTLs, Crgn1 and Crgn2 (logarithm of odds >8), were
mapped to chromosome 13 and chromosome 16, respectively.
EAG is a distinct model of crescentic nephritis that, rather than
relying on passive transfer of heterologous nephrotoxic antibodies
raised in another species, requires induction of autoimmunity to
the glomerular basement membrane (GBM). In our laboratory, this
is achieved by immunising rats with recombinant non-collagenous
domain of the alpha 3 chain of type IV collagen [α3(IV)NC1], the
Goodpasture autoantigen, which results in the development of
circulating and deposited autoantibodies to this component of the
GBM, and consequently CRGN (Ryan et al., 2001). As observed in
NTN, the WKY rat strain is exquisitely susceptible to the induction
of EAG, and the LEW strain is resistant (Reynolds et al., 2003). In
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SUMMARY
Crescentic glomerulonephritis (CRGN) is a major cause of human kidney failure, but the underlying mechanisms are not fully understood. Wistar
Kyoto (WKY) rats are uniquely susceptible to CRGN following injection of nephrotoxic serum, whereas Lewis (LEW) rats are resistant. Our previous
genetic studies of nephrotoxic nephritis (NTN), a form of CRGN induced by nephrotoxic serum, identified Fcgr3 and Jund as WKY genes underlying
the two strongest quantitative trait loci for NTN phenotypes: Crgn1 and Crgn2, respectively. We also showed that introgression of WKY Crgn1 or
Crgn2 individually into a LEW background did not lead to the formation of glomerular crescents. We have now generated a bicongenic strain,
LEW.WCrgn1,2, in which WKY Crgn1 and Crgn2 are both introgressed into the LEW genetic background. These rats show development of NTN
phenotypes, including glomerular crescents. Furthermore, we characterised macrophage function and glomerular cytokine profiles in this new strain.
Additionally, we show that LEW.WCrgn1,2 rats are resistant to the development of glomerular crescents that is usually induced following
immunisation with recombinant rat α3(IV)NC1, the specific Goodpasture autoantigen located in the glomerular basement membrane against which
the immune response is directed in experimental autoimmune glomerulonephritis. Our results show that the new bicongenic strain responds differently
to two distinct experimental triggers of CRGN. This is the first time that CRGN has been induced on a normally resistant rat genetic background and
identifies the LEW.WCrgn1,2 strain as a new, potentially valuable model of macrophage-dependent glomerulonephritis.
Experimental crescentic glomerulonephritis: a new
bicongenic rat model
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contrast to NTN, however, the first generation (F1; WKY × LEW)
remain resistant to the development of EAG, whereas F1 animals
backcrossed to the parental WKY strain (BC1; WKY × F1) show a
range of disease responses (Reynolds et al., 2002). These
observations suggest that susceptibility to EAG is inherited as a
complex trait distinct from susceptibility to NTN, although a recent
genome-wide linkage analysis of this BC1 population revealed a
QTL on chromosome 13, again corresponding to Crgn1, linked to
the percentage of glomerular crescents in EAG, suggesting at least
some shared genetic predisposition (Reynolds et al., 2012).
Here, we show for the first time that the CRGN-resistant LEW
rat strain develops glomerulonephritis, after a single dose of NTS,
when both Crgn1 and Crgn2 from the CRGN-susceptible WKY are
introgressed into its genetic background. We show that the presence
of both loci is necessary to promote glomerular crescent formation
in this bicongenic strain (LEW.WCrgn1,2). We also show that Crgn1
and Crgn2 alter the expression of key inflammatory cytokines in
nephritic glomeruli following NTN induction. In LEW.WCrgn1,2
bone-marrow-derived macrophages (BMDMs), Fc-receptor-
mediated phagocytosis and gene expression differ significantly from
the LEW background. Despite showing susceptibility to NTN, the
new LEW.WCrgn1,2 strain is resistant to glomerular autoantibody
deposition and to EAG. These results demonstrate the importance
of macrophage function associated with CRGN and identify the
LEW.WCrgn1,2 as a new model of macrophage-dependent CRGN.
RESULTS
LEW.WCrgn1,2 rats show susceptibility to NTN
NTN was induced in the WKY, LEW, single congenic
(LEW.WCrgn1 and LEW.WCrgn2) (n=6/group) and bicongenic
(LEW.WCrgn1,2; n=10) rat strains. After 10 days, glomerular
crescents were observed in 90±1.6% of glomeruli in WKY rats, 0%
of glomeruli in LEW, LEW.WCrgn1 and LEW.WCrgn2 rats, and,
for the first time on a normally NTN-resistant genetic background,
introgression of WKY Crgn1 and Crgn2 in LEW rats resulted in
10±4.1% of glomerular crescent formation (Fig. 1A). In conjunction
with glomerular crescent formation, prominent infiltration of
macrophages into the glomeruli was observed in WKY rats
[29±1.7% per glomerular cross section (gcs)], whereas this was
minimal in LEW glomeruli (4±0.4% per gcs), LEW.WCrgn1
glomeruli (9±1.9% per gcs) and LEW.WCrgn2 glomeruli (5±0.7%
per gcs). There was, however, a statistically significant increase in
macrophage infiltration into the glomeruli of the LEW.WCrgn1,2
strain (12±1.2% per gcs; Fig. 1B). In addition, proteinuria levels were
measured in the parental WKY and LEW strains as well as in the
LEW.WCrgn1,2 strain and single congenic strains. Although
differences in proteinuria were significant between the parental
LEW and WKY strains, as previously shown (Aitman et al., 2006;
Behmoaras et al., 2008), there was no significant difference in
proteinuria levels between the LEW and the single congenic
strains. There was, however, a highly significant increase in
proteinuria in the LEW.WCrgn1,2 rats compared with LEW rats
(Fig.  1C). Glomerular crescent formation and macrophage
infiltration are illustrated with haematoxylin and eosin (H&E) and
immunohistochemical staining for ED-1-positive cells per gcs,
respectively (Fig. 1D).
Expression of Tnfα, Nos2 and Mmp12 in glomeruli from
LEW.WCrgn1,2 rats following NTN
The key source of the proinflammatory mediators tumour necrosis
factor-α (Tnfα) and nitric oxide synthase 2 (Nos2; formerly known
as inducible Nos or iNos) in the glomeruli is through the infiltration
of macrophages (Cook et al., 1994; Tipping et al., 1991). At 10 days
after the induction of NTN, nephritic glomeruli were extracted and
the expression levels of glomerular Tnfα and Nos2, analysed by
quantitative real-time PCR (qRT-PCR), were used to assess the
extent of glomerular macrophage activation. Introgression of Crgn1
and Crgn2 from the CRGN-susceptible WKY into the genetic
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RESOURCE IMPACT
Background
Crescentic glomerulonephritis (CRGN) is a major cause of loss of kidney
function, which, if left untreated, can lead to fatal renal failure. The histological
features of CRGN, notably the presence of crescent-shaped scars in the
glomeruli, are widely recognised; however, the molecular mechanisms
underlying the disease are not completely understood. The rat has proven to be
an ideal model for studies of different forms of CRGN, because the resulting
histology closely resembles that of human CRGN and the molecular
phenotypes are largely reproducible. In contrast, mouse models of CRGN suffer
drawbacks, namely that the experiments are difficult to standardise and pre-
immunisation of mice is required. Among the commonly used experimental rat
strains, the Wistar Kyoto (WKY) rat strain is susceptible to induction of CRGN,
whereas the Lewis (LEW) rat strain is resistant. Two genetic loci (Crgn1 and
Crgn2) that are linked to CRGN susceptibility have been identified and congenic
strains (strains that carry a specific genomic region from another strain; the
remainder of their genome is their own) carrying Crgn1 and/or Crgn2 in either
the WKY or LEW genetic background have been generated. These reciprocal
congenic strains are valuable resources for studying the effect of these loci on
susceptibility to CRGN. Introgressing LEW Crgn1 and Crgn2 loci into the WKY
(CRGN-susceptible) genome has been shown to reduce the incidence of
disease, but the effects exerted by both WKY Crgn1 and Crgn2 in a LEW (CRGN-
resistant) genome have not been previously investigated.
Results
The authors generated a new bicongenic rat strain (LEW.WCrgn1,2) by
introgressing CRGN-susceptible WKY Crgn1 and Crgn2 into the genetic
background of the CRGN-resistant LEW strain. Two distinct forms of CRGN,
nephrotoxic nephritis (NTN) and experimental autoimmune
glomerulonephritis (EAG), were induced in LEW.WCrgn1,2 rats via passive
transfer of heterologous nephrotoxic antibodies raised in another species or
induction of autoimmunity to the glomerular basement membrane,
respectively. In the NTN model, the introgression of WKY Crgn1 and Crgn2
resulted in disease onset and increased macrophage activity in the normally
CRGN-resistant LEW strain. In addition, the gene expression profiles for
glomerular cytokines were significantly different in the bicongenic rat strain
affected by NTN compared with the parental LEW strain. Interestingly, the new
bicongenic rat strain did not show signs of disease in the EAG model,
indicating that resistance to this form of CRGN is retained. 
Implications and future directions
These results indicate differential responses of the new bicongenic rat strain to
the induction of NTN and EAG, suggesting that different mechanisms drive
these distinct forms of CRGN. The study substantiates previous evidence that
macrophage activation is an important aspect of disease development, and
provides new insights into the genes and pathways involved in macrophage-
dependent CRGN. This is the first time that CRGN has been successfully
induced in the normally resistant LEW strain; the resulting experimental model
could be useful for the identification of additional CRGN-associated loci.
Furthermore, the model could enable dissection of the mechanisms
underlying progression from serological autoimmunity to glomerular damage
and EAG, to which the strain is resistant.
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background of the CRGN-resistant LEW significantly increased
glomerular Tnfα and Nos2 levels compared with the parental LEW
strain (Fig. 2A,B). In addition, we assessed glomerular expression
of matrix metalloproteinase-12 (Mmp12), a protease associated
with the degradation of GBM, as a readout of NTN-mediated
glomerular inflammation and showed that Mmp12 was significantly
overexpressed in LEW.WCrgn1,2 rat nephritic glomeruli when
compared with parental LEW rats (Fig. 2C).
LEW.WCrgn1,2 rats show resistance to EAG
EAG was induced by immunisation with recombinant rat
α3(IV)NC1. Disease in this model has a more gradual onset relative
to NTN, reflecting the time required for adaptive immune
responses to be initiated; as a result, animals were observed for 28
days following disease induction. As previously reported (Reynolds
et al., 2003), the WKY rat strain was susceptible to the induction
of EAG, and all animals showed marked crescent formation,
glomerular macrophage infiltration and proteinuria by day 28. The
LEW strain was entirely resistant to induction of EAG, with no
animals demonstrating features of disease. The LEW.WCrgn1,2
bicongenic rat strain was also resistant, showing no significant
differences from the parental LEW strain in all three phenotypic
disease parameters (Fig. 3A-C). All three strains had similar levels
of circulating anti-GBM antibodies (Fig. 3D), although significant
levels of deposited anti-GBM antibodies, as demonstrated by
direct immunofluorescence, were found in the WKY strain alone
(Fig. 3E,F).
Measurement of Fc-receptor-dependent and -independent
macrophage activation in the LEW.WCrgn1,2 strain
To examine the combined effect of these loci on the functional
phenotype of BMDMs, we carried out activation assays that could
reflect the activity of BMDMs in vivo. Superoxide anion is a reactive
oxygen species produced by phagocytes such as macrophages in
response to appropriate stimuli. Levels of superoxide produced by
BMDMs from WKY, LEW and LEW.WCrgn1,2 rats were detected
by chemiluminescence following stimulation with phorbol 12-
myristate 13-acetate (PMA) (Fig. 4A). The kinetics of superoxide
production were significantly different between the WKY versus
the LEW and LEW.WCrgn1,2 strains, because WKY BMDMs
produced superoxide at an earlier time-point after stimulation
compared with the LEW and LEW.WCrgn1,2 BMDMs (Fig. 4A).
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Fig. 1. NTN phenotypes in parental and congenic rat strains. (A)Percentage of glomeruli with crescent formation. (B)Macrophage infiltration quantified by
the percentage of ED1+ cells per glomerular cross-section. (C)Measurement of proteinuria. ***P<0.001; *P<0.05 between LEW.WCrgn1,2 and LEW rats using one-
way ANOVA with Newman-Keuls comparison test. WKY, LEW, LEW.WCrgn1, LEW.WCrgn2 rats, n=6; LEW.WCrgn1,2 rats, n=10, except for proteinuria, where n=9.
(D)H&E staining (upper panels) and ED-1 (CD68) immunohistochemistry (lower panels) of glomeruli 10 days after injection with NTS. The H&E stain showed
crescentic glomeruli in WKY rats and, for the first time, formation of glomerular crescents in a LEW-derived strain (LEW.WCrgn1,2), whereas LEW rats were
resistant to crescent formation. ED-1 immunohistochemistry also showed a significant influx of glomerular macrophages in the LEW.WCrgn1,2 strain. 
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There was, however, no significant difference in superoxide
production between the bicongenic LEW.WCrgn1,2 and parental
LEW BMDMs. Macrophage activation was also analysed using Fc-
mediated phagocytosis (Fig. 4B,C). Notably, there was a significant
difference in phagocytic activity between the LEW and
LEW.WCrgn1,2 strains. These data indicate that introgressing
both WKY Crgn1 and Crgn2 into the genetic background of the
LEW strain had an effect on Fc-mediated phagocytosis but not on
PMA-mediated superoxide production.
Expression of Nos2, Arg1, Il10, Lilrb3l and Nov in BMDMs
Macrophages have been broadly classified according to their
activation phenotypes as M1 or M2 macrophages. M1 macrophages
are capable of secreting proinflammatory mediators such as
cytokines and are strongly microbicidal, whereas M2 macrophages
secrete anti-inflammatory cytokines, promoting wound-healing,
immune regulation and resolution of inflammation (Mosser and
Edwards, 2008). We have previously determined the macrophage
transcriptome of NTN-susceptible WKY and NTN-resistant LEW
rats by identifying ~700 differentially expressed transcripts between
the BMDMs of the two strains (Maratou et al., 2011). To examine
the effect of LEW Crgn1 and Crgn2 on the macrophage
transcriptome, we assessed the expression of M1 and M2 markers
(Nos2 and Il10, respectively), as well as the most robustly
differentially expressed transcripts (Arg1, Lilrb3l and Nov) between
WKY and LEW BMDMs. Analysis of expression levels was carried
out by qRT-PCR of mRNA from BMDMs either stimulated with
lipopolysaccharide (LPS, 100 ng, 4 hours) (Nos2, Il10, Arg1, Lilrb3l)
or in the basal state (Nov). There was significantly enhanced
expression of the proinflammatory cytokine Nos2 in
LEW.WCrgn1,2 BMDMs compared with the CRGN-resistant LEW
parental strain (Fig. 5A). The presence of Crgn1 and Crgn2 in
LEW.WCrgn1,2 rats significantly lowered the expression of the anti-
inflammatory cytokine Il10 to levels similar to that in the CRGN-
susceptible WKY strain (Fig. 5B). Introgression of Crgn1 and Crgn2
also caused a reduction in the levels of Lilrb3l and Nov (Fig. 5C,D),
and conversely showed an increased trend in levels of Arg1 in
BMDMs from LEW.WCrgn1,2 rats compared with expression
levels from parental LEW BMDMs in the same condition (Fig. 5E).
DISCUSSION
GN is a leading cause of human kidney failure, but the underlying
pathogenesis is incompletely understood. The WKY model has
contributed substantially to understanding the molecular basis of
CRGN, with identification of Fcgr3 and Jund as susceptibility genes
(Aitman et al., 2006; Behmoaras et al., 2008). We report here the
generation and phenotypic characterisation of a new rat model of
CRGN, on the normally resistant LEW genetic background. We
dmm.biologists.org1480
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Fig. 2. Tnfα, Nos2 and Mmp12
expression from nephritic
glomeruli. (A)Pro-inflammatory
cytokine Tumour necrosis factor-α;
(B) nitric oxide synthase-2; and (C)
matrix metalloproteinase-12
expression measured in nephritic
glomeruli 10 days after induction
of NTN. Analyses carried out by
qRT-PCR. ***P<0.001 between
LEW.WCrgn1,2 and LEW rats using
one-way ANOVA with Newman-
Keuls comparison test. n=4 in all
strains.
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replaced the LEW alleles for Fcgr3 and Jund with the corresponding
WKY alleles, creating a new bicongenic strain, LEW.WCrgn1,2, and
found that this strain is susceptible to NTN, including the
development of glomerular crescents, but is resistant to the related
CRGN phenotype EAG. Characterisation of cytokine profiles and
functional testing of the LEW.WCrgn1,2 glomeruli and
macrophages provide preliminary insights into the genes and
pathways leading to development of CRGN in this new model.
Our earlier research focussed on the genetic dissection of CRGN
in segregating populations derived from the CRGN-susceptible and
CRGN-resistant rat strains, WKY and LEW, respectively. The two
CRGN susceptibility loci, Crgn1 and Crgn2, identified by genome-
wide linkage analysis and functional studies, showed the deletion
of Fcgr3-rs to be the cause of macrophage overactivity at Crgn1
(Aitman et al., 2006), and, subsequently, the marked upregulation
of Jund at Crgn2 was associated with increased macrophage
activation (Behmoaras et al., 2008; Hull et al., 2013).
In addition, we have described the effects of NTN on a double
congenic rat strain for chromosomes 13 and 16 (WKY.LCrgn1,2)
generated by introgressing LEW Crgn1 and Crgn2 into the genetic
background of the WKY strain. The LEW Crgn1 and Crgn2 loci
conferred marked additive protective effects on NTN phenotypes
in WKY.LCrgn1,2 rats, as seen by a significant reduction in
glomerular crescent formation, macrophage infiltration and
proteinuria compared with parental WKY rats. The WKY.LCrgn1,2
strain also showed reduced levels of glomerular cytokines, protease
production and Nos2, as well as reduced macrophage activation
(Behmoaras et al., 2010). Although this study by Behmoaras et al.
allowed the extent of the roles of LEW Crgn1 and Crgn2 in CRGN
susceptibility to be examined, the effects of WKY Crgn1 and Crgn2
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Fig. 3. EAG phenotypes and autoantibody responses in parental (WKY and LEW) and double congenic (LEW.WCrgn1,2) rat strains at day 28.
(A)Percentage of glomeruli with crescents. (B)Macrophage infiltration quantified by the percentage of ED1+ cells per glomerular cross-section. (C)Measurement
of proteinuria. (D)Serum circulating anti-GBM antibody levels, showing similar serological autoimmunity in all three strains. (E)Quantification of deposited anti-
GBM antibody (graded 0 to 3+ intensity) in each rat strain assessed by direct immunofluorescence (IF) for anti-rat immunoglobulins. (A-E)Statistically significant
differences in mean values between the LEW.WCrgn1,2 strain and LEW strain compared using a one-way ANOVA with Newman-Keuls comparison test. ns: non-
significant. WKY and LEW rats, n=6; LEW.WCrgn1,2 rats, n=10. (F)Representative direct immunofluorescence images showing pattern and intensity of anti-GBM
antibody deposition in glomeruli in each rat strain.
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on a LEW genetic background, in NTN or EAG studies, were so-
far unknown.
In this study, we report a new bicongenic rat strain,
LEW.WCrgn1,2, in which the CRGN-susceptible WKY loci (Crgn1
and Crgn2) have been introgressed into a CRGN-resistant LEW
genetic background. We investigated susceptibility of this new
LEW.WCrgn1,2 strain to two distinct models of macrophage-
dependent CRGN (NTN – requiring passive transfer of
heterologous nephrotoxic antibodies raised in another species –
and EAG – requiring induction of autoimmunity to the GBM)
compared with the LEW strain. We found that the presence of these
WKY CRGN loci in the LEW.WCrgn1,2 strain led, for the first time,
to significant crescent formation, infiltration of macrophages and
proteinuria, after a single dose of NTS, in a rat strain with a LEW
genetic background. It is important to highlight that the LEW rat
strain has been used consistently in NTN studies as a robustly
reproducible negative control (Aitman et al., 2006; Behmoaras et
al., 2008; Behmoaras et al., 2010; Hull et al., 2013; Maratou et al.,
2011; Page et al., 2012; Smith et al., 2007). Our findings demonstrate
that, when the two CRGN susceptibility loci (Crgn1 and Crgn2)
from the WKY strain are introgressed into the LEW strain, this
CRGN-resistant strain develops glomerular crescents, a hallmark
of CRGN, and that the presence of both Crgn1 and Crgn2 are
essential for the development of disease.
Macrophages are well recognised mediators of glomerular injury
in CRGN (Cattell, 1994; Cook et al., 1999; Duffield, 2010; Isome et
al., 2004; Williams et al., 2010), and the importance of macrophage
number and activity within the glomerulus for crescent formation
and disease progression has been previously established in rat
models of CRGN (Behmoaras et al., 2010; Isome et al., 2004;
Munger et al., 1999). The presence of the proinflammatory
cytokines Tnfα and Nos2 in the glomerulus comes largely from
infiltrating macrophages (Cook et al., 1994; Tipping et al., 1991).
Furthermore, Mmp12, which is secreted by macrophages, enables
degradation of extracellular matrix components, such as those of
the GBM (Kaneko et al., 2003). We found that the expression of
Tnfα, Nos2 and Mmp12 was significantly increased in the nephritic
glomeruli of LEW.WCrgn1,2 rats compared with parental LEW rats.
Interestingly, levels of nephritic glomerular Tnfα in the
LEW.WCrgn1,2 rats were comparable with those in WKY rats,
despite a significant difference in infiltrating macrophage numbers
into the glomeruli between the two strains, suggesting that
glomerular Tnfα levels might indicate macrophage activation rather
than infiltration.
In order to assess and compare the functional phenotype of
macrophages from the WKY, LEW and bicongenic
LEW.WCrgn1,2 strains, we carried out two tests, namely, a
superoxide anion detection assay and an Fc-mediated bead
phagocytosis assay. Superoxide, a reactive oxygen species, is
produced by activated phagocytes, such as macrophages, as part
of their biological defence mechanism (Babior et al., 1973;
Robinson, 2009). In vitro, macrophages can be stimulated to
generate superoxide by PMA. PMA, a phorbol ester, is a potent
inflammatory and tumour-producing compound, capable of
mimicking diacylglycerol, thereby activating the protein kinase C
signalling pathway (Castagna et al., 1982; Driedger and Blumberg,
1980; White et al., 1984). The overproduction of superoxide often
leads to tissue injury at sites of inflammation (Halliwell and
dmm.biologists.org1482
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Fig. 4. Macrophage activation assays in BMDMs in parental (WKY and LEW) and double congenic (LEW.WCrgn1,2) rat strains. (A)Production of superoxide
assessed by chemiluminescence over 90 minutes, following addition of PMA (1 μM) (n=3 in all strains). (B,C)Fc-receptor-mediated phagocytic activity of BMDMs
assessed by incubating WKY, LEW and LEW.WCrgn1,2 BMDMs with beads opsonised with rabbit anti-BSA IgG, or unopsonised for 30 minutes. Cells were then
fixed and beads in 100 BMDMs were counted (n=4 in all strains).  *P<0.05 between LEW.WCrgn1,2 and LEW rats using one-way ANOVA with Newman-Keuls
comparison test.
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Gutteridge, 2006). Furthermore, superoxide produced by
macrophages has been reported to be a prominent contributor
to glomerular injury in glomerulonephritis (Cook et al., 1989).
Here, we measured superoxide produced by BMDMs from WKY,
LEW and LEW.WCrgn1,2 rats by chemiluminescence. Although
the amount and the kinetics of superoxide production differed
significantly between the WKY and LEW BMDMs, there was no
difference between the LEW and the LEW.WCrgn1,2 BMDMs,
indicating that WKY Crgn1 and Crgn2 had no influence on the
protein kinase C signalling pathway, when introgressed into a
LEW genetic background.
Fc receptors for IgG (Fcgr) have been shown to facilitate
phagocytosis and antibody-dependent cellular cytotoxicity in
rodent macrophages (Aitman et al., 2006; Behmoaras et al., 2008;
Behmoaras et al., 2010; Mosser and Zhang, 2008). We have
previously shown that the absence of an Fc-related sequence
(Fcgr3-rs) causes macrophage overactivity and NTN susceptibility
in the WKY strain, whereas, conversely, the LEW strain, which has
Fcgr3-rs, is resistant to NTN and shows no macrophage overactivity
(Aitman et al., 2006; Page et al., 2012). Consistent with this, Fc-
mediated bead phagocytosis levels were higher in WKY BMDMs
than in LEW BMDMs. Notably, by introgressing the WKY Fcgr3
gene in the Crgn1 locus, along with Crgn2, into the genetic
background of the LEW strain, we observed an increase in
phagocytosis in LEW.WCrgn1,2 BMDMs, reflecting macrophage
activation in this strain brought about by the synergistic influence
of Crgn1 and Crgn2.
In the NTN model, Crgn1 and Crgn2 exert their influence chiefly
on bone-marrow cells, specifically BMDMs, rather than on intrinsic
renal cells (Behmoaras et al., 2010). Because of this, we analysed
the effects of WKY Crgn1 and Crgn2 in LEW.W.Crgn1,2 rats on
BMDM gene expression and found that these two CRGN
susceptibility loci caused a significant increase in expression of the
proinflammatory cytokine Nos2, and conversely a reduction in
expression of the anti-inflammatory cytokine Il10, when compared
with parental LEW BMDMs. Our previous work characterised
macrophage transcriptomes of the WKY and LEW strains, which
revealed highly significant differentially expressed genes between
WKY and LEW BMDMs (in basal or LPS-stimulated states) that
are in effector pathways for macrophage-mediated damage in
CRGN (Maratou et al., 2011). We found that, in LEW.WCrgn1,2
BMDMs, there was a significant decrease in expression levels of
genes that are normally overexpressed in LEW BMDMs (Lilrb3l,
Nov) and conversely an increasing trend of Arg1 expression
(normally overexpressed in WKY BMDMs) in LEW.WCrgn1,2
BMDMs compared with LEW BMDMs. This correlates with the
important effects exerted by WKY Crgn1 and Crgn2 on the LEW
genome, whereby the introgression of these CRGN susceptibility
QTLs causes the LEW BMDMs to have a similar phenotype to that
of the WKY strain.
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Fig. 5. Gene expression profiles in BMDMs in parental (WKY and LEW) and double congenic (LEW.WCrgn1,2) rat strains. (A)Pro-inflammatory cytokine
Nos2; (B) anti-inflammatory cytokine Il10; (C) Lilrb3l; (D) Nov and (E) Arg1 expression in LPS-stimulated BMDMs (except Nov, for which BMDMs in basal state).
Expression analyses were carried out by qRT-PCR. ***P<0.001; **P<0.01; P was non-significant (ns) between LEW.WCrgn1,2 and LEW rats using one-way ANOVA
with Newman-Keuls comparison test. n=4 biological rats per strain with three technical replicates per rat. BMDMs were untreated (basal) or stimulated with 100
ng LPS for 4 hours.
D
ise
as
e 
M
od
el
s &
 M
ec
ha
ni
sm
s  
    
   D
M
M
In contrast to NTN, the bicongenic LEW.WCrgn1,2 strain was
resistant to EAG. Interestingly, previous work by our group has
shown that WKY.LCrgn1 single congenic animals show significant
protection from disease in EAG (Reynolds et al., 2012). The failure
to confer susceptibility to EAG in the bicongenic LEW.WCrgn1,2
strain, however, confirms our previous observation that
susceptibility to EAG has a different mode of inheritance to NTN
(Reynolds et al., 2002), with likely roles for additional susceptibility
loci. It is intriguing that both LEW.WCrgn1,2 and parental LEW
rats make similar levels of circulating anti-GBM antibodies to WKY
rats, but do not show significant deposition on the GBM. We can
hypothesise a number of possible reasons. Firstly, it might be that
the antibodies differ between strains in terms of epitope specificity,
affinity or IgG subclass. Secondly, there might be differences in
accessibility of the epitopes in the GBM between strains, perhaps
related to concomitant T-cell-mediated injury in the WKY strain;
however, anti-GBM antibodies eluted from the kidneys of WKY
rats can bind to the GBM of LEW rats (Reynolds et al., 2012). The
failure of the bicongenic LEW.WCrgn1,2 strain, like LEW, to
develop deposited autoantibody in the glomerulus suggests that
EAG susceptibility is most likely under the influence of additional
WKY loci that control glomerular autoantibody deposition. These
loci must reside outside the rat MHC, because WKY and LEW
strains share a common RT-1 haplotype (RT1l). The identification
of these additional loci that confer protection in LEW and LEW-
related strains, yet susceptibility in the WKY strain, is the subject
of our ongoing work.
Our future work aims to investigate the effect of WKY Crgn1
and Crgn2 in the bicongenic strain across the entire transcriptome.
The LEW.WCrgn1,2 strain will also provide the basis for future
work to define the mechanisms underlying the progression from
serological autoimmunity (which is shown in the LEW.WCrgn1,2
strain), through glomerular autoantibody deposition (absent in the
LEW.WCrgn1,2 strain), to glomerular inflammation (absent in the
LEW.WCrgn1,2 strain, but to which it is critically susceptible, unlike
the parental LEW strain).
In conclusion, our study has shown, for the first time, the
formation of glomerular crescents in NTN in a rat strain with a
LEW genetic background, which is normally resistant to NTN.
Despite showing susceptibility to NTN, the new bicongenic
LEW.WCrgn1,2 strain is resistant to glomerular autoantibody
deposition and to EAG. These data emphasise the importance of
Crgn1 and Crgn2 on NTN susceptibility and show the potential
value of the LEW.WCrgn1,2 strain for future studies of macrophage-
dependant glomerulonephritis.
MATERIALS AND METHODS
Generation of congenic rat strains
Parental WKY (WKY/NCrl) and LEW (LEW/Crl) rats were
purchased from Charles River. Generation of the bicongenic rat
strain, LEW.WCrgn1,2, was achieved as follows: single congenic
strains LEW.WCrgn1 and LEW.WCrgn2 (Behmoaras et al., 2008)
were crossed to produce an F1 population that was then backcrossed
to LEW.WCrgn1. Backcross animals that were heterozygous for
Crgn2 and homozygous for Crgn1 were selected and crossed by
brother-sister mating to obtain animals that were bicongenic for
WKY Crgn1 and Crgn2 on a LEW genetic background. The
congenic intervals and microsatellite markers used for genotyping
were as described previously (Behmoaras et al. 2010), with the
difference being the reversal of donor and recipient strains used in
the present study. All procedures were performed in accordance
with the United Kingdom Animals (Scientific Procedures) Act,
1986.
NTN and nephritic glomeruli isolation
NTS was prepared as previously described (Bhan et al., 1978). NTN
was induced in 8-week-old male WKY, LEW, LEW.WCrgn1,
LEW.WCrgn2 and LEW.WCrgn1,2 rats by intravenous injection of
0.1 ml of NTS. Nine days later, urine was collected by placing rats
in metabolic cages for 24 hours with free access to food and water.
Proteinuria was determined by the sulphosalicylic acid test (Baker
et al., 1998). Ten days after NTN induction, rats were culled by
asphyxiation with CO2 and cervical dislocation, glomeruli were
isolated from one kidney each from all strains (four rats per strain)
while the other kidney from all strains was formalin-fixed and
paraffin embedded. Glomerular isolation was carried out as
described (Deplano et al., 2013). Glomerular pellets were then
resuspended in TRIzol® (Invitrogen).
Induction and assessment of EAG
Six-week-old female WKY, LEW and LEW.WCrgn1,2 rats were
immunized with 0.5  mg/kg recombinant rat α3(IV)NC1 in
complete Freund’s adjuvant by intramuscular injection. After 28
days, urine, serum and tissues were collected and proteinuria
determined as described for NTN animals. Serum anti-GBM
antibody concentrations were assayed as described previously
(Ryan et al., 2001). Glomerular deposition of anti-GBM antibodies
was detected by direct immunofluorescence (Reynolds et al., 2012).
Histology and immunohistochemistry
To quantify the degree of histological injury in both the NTN and
EAG models, 4  μm formalin-fixed paraffin-embedded kidney
sections were stained with H&E and periodic acid-Schiff (PAS).
100 consecutive glomeruli were assessed in a blinded manner, and
the number of severely crescentic glomeruli expressed as a
percentage of total glomeruli examined. To quantify the number
of macrophages that infiltrated into glomeruli, formalin-fixed
paraffin-embedded kidney sections were stained with mouse
monoclonal antibody to ED-1 (Serotec, Oxford, UK), followed by
an HRP-labelled anti-mouse polymer development system (Dako
Ltd, UK). The cellular infiltrate in 20 consecutive glomeruli was
quantified using automated image analysis software (ImagePro Plus,
Media Cybernetics, Bethesda, MD) and expressed as a percentage
of total glomerular cross-sectional area.
BMDM culture, bead phagocytosis and superoxide anion
detection
BMDMs were obtained and characterised as described previously
(Behmoaras et al., 2010). Bone-marrow cells were allowed to
differentiate in Dulbecco’s modified Eagle’s medium (DMEM;
Gibco) containing 25  mM HEPES buffer (Sigma), 25% L929-
conditioned medium, 25% fetal bovine serum (Biosera), penicillin
(100 U/ml; Gibco) and streptomycin (100  μg/ml; Gibco), and
cultured for 5 days on Petri dishes (Nunc).
Macrophage phagocytosis was assessed as described (Behmoaras
et al., 2008; May et al., 2000). Dissociated day-5 BMDMs were
dmm.biologists.org1484
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allowed to adhere overnight to eight-well chamber slides (Nunc)
at a cell density of 105 cells per chamber. After addition of 6-μm
polystyrene beads (Polysciences), unopsonised or opsonised with
rabbit anti-BSA IgG (Sigma) (Behmoaras et al., 2008), the chamber
slides were incubated for 30 minutes at 37°C, 5% CO2, followed by
a wash with 1× PBS and fixed with Diffquick (Medion Diagnostics).
The reactive oxygen species, superoxide anion, was assessed by
a chemiluminescence assay (LumiMax Superoxide Anion Detection
Kit, Stratagene), wherein relative luminescence units (RLU)
corresponded to superoxide levels produced by BMDMs. Briefly,
day-5 BMDMs were dissociated using cell dissociation solution
(Sigma) and allowed to adhere overnight to a 96-well optical bottom
plate (Nunc) at a cell density of 2.5×105 cells per well with BMDMs
plated from four rats/strain in triplicate. Prior to the assay, cells
were washed and PMA (1 μM; Sigma) was used to generate
superoxide production by BMDMs. A time-dependent increase in
chemiluminescence was detected using the Fluostar Galaxy plate
reader (BMG Labtech) and the RLU values were detected for a total
period of 100 minutes.
RNA extraction and real-time quantitative RT-PCR
Total RNA was extracted from nephritic glomeruli and BMDMs
using the TRIzol® method, which was then quantified using the
NanoDrop®ND-1000 Spectrophotometer (Thermo Scientific). Real-
time quantitative RT-PCR was carried out using the 7500 Fast Real
Time PCR System (Applied Biosystems) and the Brilliant® SYBR®
Green QRT-PCR kit (Agilent Technologies). 100 ng of total RNA
was utilised for qRT-PCR, with each sample amplified in duplicate.
Samples were first subjected to reverse transcription (30 minutes
at 50°C and 10 minutes at 95°C) followed by cycling 40 times at
95°C for 15 seconds and 60°C for 1 minute. Primer sequences are
available upon request. Results obtained were exported to the 7500
Fast System SDS software (Applied Biosystems), where Ct values
were determined and normalised to glyceraldehyde-3-phosphate
dehydrogenase gene expression. Relative expression levels were
then determined using the 2–ΔΔCt method.
Statistical analysis
Results are expressed as mean ± s.e.m. Statistical differences in
mean values between the bicongenic LEW.WCrgn1,2 strain and
parental LEW rats were compared using a one-way ANOVA with
Newman-Keuls comparison test.
Deposition of resource in a repository
The new bicongenic LEW.WCrgn1,2 rat strain will be available as
a resource from the National BioResource Project (NBRP) – Rat,
Kyoto University, Kyoto Japan.
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